Moxifloxacin: new preparation. A me-too with more cardiac risks.  [electronic resource] 

 -  Prescrire international  Dec 2002 
 - 168-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1167-7422 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Bacterial Agents--adverse effects<br/>Anti-Infective Agents--adverse effects<br/>Ciprofloxacin--adverse effects<br/>Drug Approval<br/>Fluoroquinolones--adverse effects<br/>France<br/>Humans<br/>Levofloxacin<br/>Long QT Syndrome--chemically induced<br/>Ofloxacin--adverse effects<br/>Pneumonia--drug therapy